Whalegun
Home

Samuel Kintz, President and CEO: Enliven Therapeutics ELVN Sell · Filed 23/09/26

Trade details

Type
Insider sale
Amount
$165,720
Shares · price
12,000 sh · $13.81 a share
Held after
0 sh
Stock
Enliven Therapeutics ELVN
Person
Samuel KintzPresident and CEO
Trade date
23/09/25
Filed
23/09/26
Days to filing
1 days

Sold 100.0% of holdings

Share of holding sold
100.0%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 23/08/26~23/10/25

Samuel Kintz's recent trades

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $2M

    Filed 02/17

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $1.7M

    Filed 01/09

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $1.3M

    Filed 01/08

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $84.6K

    Filed 25/12/17

  • Samuel Kintz

    Sell10b5-1 planEnliven Therapeutics

    $272.8K

    Filed 25/11/19